Regulation of the hypoxia-inducible factor-l α (HIF-l α): A breath of fresh air in hypoxia research;La régulation de HIF-lα (Hypoxia-Inducible factor-lot): un air nouveau dans le domaine de l'hypoxie

Journal de la Societe de Biologie

Volumn 198, Issue 2, 2004, Pages 113-120

  Berta, Mélanie ^a   Brahimi Horn, Christiane ^a   Pouyssegur, Jacques ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL; ANOXIA; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; ANOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSCRIPTION FACTORS;

EID: 16544384256     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio/2004198020113     Document Type: Article

References (44)

1. Berra E., Benizri E., Ginouves A., Volmat V., Roux D. & Pouyssegur J., HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. Embo. J. 2003, 22, 4082-4090.
2. 2ydriven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. Embo. Rep., 2001, 7, 615-620.
3. Bruick R. K. & Mcknicht S. L., Building better vasculature. Genes Dev. 2001, 15. 2497-2502.
4. Deroanne C. F., Bonjean K., Servotte S., Devy L., Colige A., Clausse N., Blacher S., Verdin E., Foidart J. M., Nusgens B. V. & Castronovo V., Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene, 2002, 21, 427-436.
5. Desterro J. M., Rodriguez M. S. & Hay R. T., SUMO-1 modification of 1kBα inhibits NF-kappaB activation. Mol. Cell. 1998, 2, 233-239.
6. Drutel G., kathmann M., Heron A., Gros C, Mace S., Schwartz J. C. & Arrang J. M., Two splice variants of the hypoxia- inducible factor HIF-1α as potential dimerization partners of ARNT2 in neurons. Eur. J. Neurosci. 2000, 12, 3701-3708.
7. Epstein A.C.,Gleadle J.M.,McNeill L.A.,Hewitson K.S.,O'Rourke J.,Mole D.R.,Mukherji M.,Metzen E.,Wilson M.I.,Dhanda A.,Tian Y.M.,Masson N.,Hamilton D.L.,Jaakkola P.,Barstead R.,Hodckin J.,Maxwell P.H.,Pugh C.W.,Schofield C.J.,Ratcliffe P.J.C.elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by proTyl hydroxylation.Cell,2001,107,43-54.
8. Epstein A. C, Gleadle J. M., McNeill L. A., Hewitson K. S., O'Rourke J., Mole D. R., Mukherji M., Metzen E., Wilson M. I., Dhanda A., Tian Y. M., Masson N., Hamilton D. L., Jaakkola P., Barstead R., Hodckin J., Maxwell P. H., Pugh C. W., Schofield C. J. & Ratcliffe P. J., C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by proTyl hydroxylation. Cell, 2001, 107, 43-54. Gomie., Richard D. E., Berra E., Pages G. & Pouyssegur J., Identification of alternative spliced variants of human hypoxia- inducible factor-lα J. Biol. Chem., 2000, 275. 6922-6927.
9. Hirsila M., koivunen P., Gunzler V., kivirikko K. I. & Mylly- harju J., Characterization of the human prolyl 4-hydroxy- lases that modify the hypoxia-inducible factor. J. Biol Chem., 2003, 275, 30772-30780.
10. Huang L. E., Gu J., Schau M. & Bunn H. F., Regulation of hypoxia- inducible factor la is mediated by an 0, -dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 1998, 95. 7987-7992.
11. Huang L. E., YVilhnore \V. G., Gu J., Goldberg M. A. & Bunn H. F., Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and sianalina. J. Biol. Chem. 1999, 274, 9038-9044.
12. Ivan M., kondo K., Yang H., kim W., Valiando J., Ohh M., Salic A., Asara J. M., Lane W. S. & kaelin W. G., Jr., FIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001, 292, 464-468.
13. Iyer N. V., Leung S. W. & Semenza G. L., The human hypoxia- inducible factor lα gene: HIF1A structure and evolutionary conservation. Genomics, 1998, 52, 159-165.
14. Jaakkola P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J., kriegsheim A., Hebestreit H. F., Mukherji M., Schofield C. J., Maxwell P. H., Pugh C. W. & Ratcliffe P. J., Targeting of HIF-a to the von Hippel-Lindau ubiqui- tylation complex by O2-regulated prolyl hydroxylation. Science, 2001, 292, 468-472.
15. Jeong J. W., Bae M. K., Aim M. Y., kim S. H., Sohn T. K., Bae M. H., Yoo M. A., Song E. J., Lee K. J. & kim K. W., Regulation and destabilization of HIF-lα by ARDI-media- ted acetylation. Cell, 2002, 111, 709-720.
16. Jia L., Bonaventura C, Bonaventura J. & Stamler J. S., S-nitroso- haemoglobin: a dynamic activity of blood involved in vascular control. Nature, 1996, 380, 221-226.
17. kallio P. J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H. & Poellinger L., Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-la. Embo. J., 1998, 17, 6573-6586.
18. kim M. S., kwon H. J., Lee Y. M., Baek J. H., Jang J. E., Lee S. W. Moon E. J., kim H. S., Lee S. K., Chung H. Y., Kim C. W. & Kim K. W., Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 2001 7. 437-443.
19. koivunen P., Hirsila M., Gunzler V., kivirikko K. I. & Mylly-harju J., Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 2004, 279, 9899-9904.
20. kouzarides T., Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 1999, 9, 40-48.
21. kouzarides T., Acetylation: a regulatory modification to rival phosphorylation ? Embo. J. 2000, 19. 1176-1179.
22. krieg M., Haas R., Brauch H., Acker T., Flamme I. & Plate K. H., Up-regulation of hypoxia-inducible factors HIF-la and HIF-2α under nonnoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene, 2000, 19, 5435-5443.
23. Lando D., Peet D. J., Gorman J. J., Whelan D. A., Whitelaw M. L. & Bruick R. K., FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev., 2002, 16. 1466-1471.
24. Lee E., Yim S., Lee S. K. & Park H., Two transactivation domains of hypoxia-inducible factor-la regulated by the MEk-l/p42/p44 MAPk pathway. Mol. Cells. 2002, 14. 9-15.
25. Liu Y., Christou H., Morita T., Laughner E., Semenza G. L. & kourembanas S., Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J. Biol. Chem., 1998, 273, 15257-15262.
26. Mahajan R., Delphin C, Guan T., Gerace L. & Melchior F., A small ubiquitin-related polypeptide involved in targeting RanGAPl to nuclear pore complex protein RanBP2. Cell, 1997, 88, 97-107.
27. Mahon P. C, Hirota K. & Semenza G. L., FIH-1: a novel protein that interacts with HIF-lα and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev., 2001, 15, 2675-2686.
28. Melchior F.SUMO-nonclassical ubiquitin.Annu. Rev. Cell Dev. Biol.2000,16,591-626.
29. Melchior F., SUMO-nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 2000, 16, 591-626. Palmer L. A., Gaston B. & Johns R. A., Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol. Pharmacol, 2000, 55, 1197-1203.
30. Richard D. E., Berra E., Gothie E., Roux D. & Pouyssegur J., p42/p44 mitogen-activated protein kinases phosphorylate hypoxia- inducible factor lα (HlF-lα) and enhance the transcriptional activity of HIF-1.7. Biol. Chem., 1999, 274, 32631-32637.
31. Ross S., Best J. L., Zon L. I. & Gill G., SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell. 2002, 10, 831-842.
32. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F. & Gros- schedl R., PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev., 2001, 15. 3088-3103.
33. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F. & Suske G., Transcription factor Sp3 is silenced throueh SUMO modification by PIAS1. Embo. J., 2002, 21, 5206-5215.
34. Semenza G.L., HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med., 2002, 8, S62-S67.
35. Semenza G. L., Rue E. A., Iyer N. V., Pang M. G. & kearns W. G., Assignment of the hypoxia-inducible factor lα gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics, 1996, 34, 437-439.
36. Semenza G. L., Nejfelt M. K., Chi S. M. & Antonarakis S. E., Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, 1991, 88, 5680-5684.
37. Sogawa K., Numayama-Tsuruta K., Ema M., Abe M., Abe H. & Fujii-kuriyama Y., Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc. Natl. Acad. Sci. USA, 1998, 95, 7368-7373.
38. Tojo M., Matsuzaki K., Minami T., Honda Y., Yasuda H., Chiba T., Saya H., Fujii-kuriyama Y. & Nakao M., The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system. J. Biol. Chem., 2002, 277, 46576-46585.
39. Volmat V., Camps M., Arkinstall S., Pouyssegur J. & Lenor-mand P., The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases. J. Cell. Sci., 2001, 114, 3433-3443.
40. Wang G. L., Jiang D. H., Rue E. A. & Semenza G. L., Hypoxia- inducible factor 1 is a basic-helix-Ioop-helix-PAS heterodi- mer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA, 1995, 92, 5510-5514.
41. Wang G. L. & Semenza G. L., Purification and characterization of hypoxia-inducible factor 1. J. of Biol. Chem. 1995, 270, 1230-1237.
42. Wiener C. M., Booth G. & Semenza G. L., In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun., 1996, 225, 485-488.
43. Yasinska I. M. & Sumbayev V. V., S-nitrosation of Cys-800 of HIF- lα protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 2003, 549, 105-109.
44. Zhong S., Muller S., Ronchetti S., Freemont P. S., Dejean A. & Pandolfi P. P., Role of SUMO-1-modified PML in nuclear body formation. Blood, 2000, 95, 2748-2752.